Publicacions en col·laboració amb investigadors/es de St. Elizabeth's Medical Center (2)

2017

  1. Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)

    International Journal of Clinical Practice, Vol. 71, Núm. 5

2016

  1. Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

    European Urology, Vol. 70, Núm. 1, pp. 136-145